EU4Monitoring Drugs (EU4MD)

This timeline allows you to explore a timeline highlighting some of the EU4Monitoring Drugs (EU4MD) project's achievements. As part of its ongoing commitment to strengthening cooperation and sharing expertise, EMCDDA developed the EU4Monitoring Drugs (EU4MD) project, funded by the European Union....

This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia. Focused on providing insights into drug production, trafficking, sale, use and harms, the report...

This report presents an analysis of the drug markets in the European Neighbourhood Policy-East region covering Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine. Focused on providing insights into drug production, trafficking, sale, use and harms, the report contains data and information...

The European Web Survey on Drugs collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in the 21 EU and 9 non-EU countries including Ukraine. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related...

The European Web Survey on Drugs collected data during March to May 2021 from people who use drugs, are aged 18 or older and live in Georgia. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related lockdown or restrictions. Unless otherwise...

Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries. This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and...